Pectin-stabilized nanoceria double coated with lactoferrin/chitosan for management of experimental autoimmune encephalomyelitis
Colloids and Surfaces B: Biointerfaces · 2025
DOI: 10.1016/j.colsurfb.2024.114271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2025. Verfasst von Lamiaa R Abdelalim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt. Hauptthemen laut MEDLINE: Cerium, Chitosan, Encephalomyelitis, Autoimmune, Experimental, Lactoferrin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben.
Abstract (Originalsprache)
Cerium oxide nanoparticles are a unique antioxidant mimicking the activity of natural antioxidant enzymes. Previous research showed its' promising effect mitigating free radical damage in neurodegenerative disorders. However, there is still unmet therapeutic needs due to poor BBB penetration, a high accumulation in liver, kidney and spleen. This study aimed to synthesize and optimize nanoceria stabilized by natural bioactive polymers suitable for intranasal administration to manage multiple sclerosis. Among the different employed biopolymers, pectin-stabilized nanoceria exhibited the ideal properties with small particles size 87.20 ± 3.43 nm, high zeta potential -56.37 ± 2.39 mV and high free radical scavenging activity 85.27 ± 0.07 %. Then coating was achieved for the first time by two biopolymers: lactoferrin and chitosan producing a double coated cationic nanoceria. Biological assessment involved using experimental autoimmune encephalomyelitis animal model treated in a dose of 1 mg/kg nanoceria for 15 days. Motor function testing in rats revealed 6- and 17-folds increase in latency time in rotating rod and hanging wire tests, respectively. Biochemical analysis revealed significant reduction in lipid peroxidation along with about 1-fold upgrading of the intrinsic antioxidant system. Moreover, histologic examination disclosed decreased degeneration of the brain and spinal cord of treated rats and much decreased liver toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.
- Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Eg…
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Zitieren
APA
Abdelalim, L. R., Elnaggar, Y. S. R., & Abdallah, O. Y. (2025). Pectin-stabilized nanoceria double coated with lactoferrin/chitosan for management of experimental autoimmune encephalomyelitis. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2024.114271
Vancouver
Abdelalim LR, Elnaggar YSR, Abdallah OY. Pectin-stabilized nanoceria double coated with lactoferrin/chitosan for management of experimental autoimmune encephalomyelitis. Colloids and Surfaces B: Biointerfaces. 2025. doi:10.1016/j.colsurfb.2024.114271
BibTeX
@article{Abdelalim2025,
author = {Abdelalim, Lamiaa R and Elnaggar, Yosra S R and Abdallah, Ossama Y},
title = {Pectin-stabilized nanoceria double coated with lactoferrin/chitosan for management of experimental autoimmune encephalomyelitis},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2025},
doi = {10.1016/j.colsurfb.2024.114271}
}
EUVIMED